Driving Innovation in Antibody Discovery and Development Through Novel Partnership Models In this webinar, Dr Robert Williams, Chief Development Scientist, Cancer Research UK, will discuss how partnership between academia and industry can accelerate drug development.
Advanced Molecular Tools for Proteome Analyses Masood Kamali-Moghaddam, Uppsala University, speaking at Advances ibn qPCR and dPCR 2014
Conformational Changes Induced by Nanomaterials: Functional Implications Rosana Simon-Vazquez, University of Vigo, speaking at Nanomedicine 2014.
Magneto-plasmonic Nanoparticle Platform for Capture, Separation and Enumeration of Rare Cells Konstantin Sokolov, The University of Texas at Austin, speaking at Nanomedicine 2014.
Pathology is Phenotyping. What Do Pathologists Do? How Do they Do It? Dean Troyer, Provia Biologics, speaking at Exosomes and Circulating Biomarkers Summit 2013.
Monitoring Dynamic Interactions of Tumor Cells with Tissue and Immune Cells in a Lab-on-a-Chip Peter Ertl, Austrian Institute of Technology, speaking at Lab-on-a-Chip European Congress 2014.
Unravelling Pathogen Virulence Strategies through the Application of Transcriptomics and Real-time Imaging Professor Murray Grant, University of Exeter, speaking at AgriGenomics World Congress 2013.
Extracorporeal Elimination of Circulating Exosomes as a Therapeutic Adjunct to Address Infectious Disease and Cancer James Joyce, Aethlon Medical Inc, speaking at Exosomes and Circulating Biomarkers Summit 2013.
Biomarker Development to Improve Trials for Type 1 Diabetes Professor Matthias von Herrath, The La Jolla Institute for Allergy and Immunology, speaking at Exosomes and Circulating Biomarkers Summit 2013.
Selection and Molecular Profiling of Circulating Tumor Cell (CTC) Sub-populations: Single-Cell Studies of Epithelial-to-Mesenchymal Transitions Professor Steven Soper, University of North Carolina, speaking at Single Cell Analysis Summit 2013.